Immunogenicity of 2 or 3 Doses of 9vHPV Vaccine in U.S. Female Individuals 15 to 26 Years of Age.
- Resource Type
- Article
- Source
- NEJM Evidence; Feb2024, Vol. 3 Issue 2, p8-8, 1p
- Subject
IMMUNIZATION CONFIDENCE intervals VACCINE immunogenicity SEROCONVERSION RANDOMIZED controlled trials COMPARATIVE studies HUMAN papillomavirus vaccines PSYCHOLOGY of women GENOTYPES STATISTICAL sampling ADULTS ADOLESCENCE - Language
- ISSN
- 27665526